Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MIRA Pharmaceuticals, Inc. (MIRA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MIRA Pharmaceuticals, Inc. (MIRA), most recent 12 months reported: net loss $9.48M. Latest balance sheet on file: liquid cash $8.11M. From SEC filings. Others in Pharmaceutical Preparations: Moleculin Biotech, Inc. · MBX Biosciences, Inc. · MEDICUS PHARMA LTD. · Jyong Biotech Ltd. · Milestone Pharmaceuticals Inc. · MOONLAKE IMMUNOTHERAPEUTICS · MINERALYS THERAPEUTICS, INC. · Monopar Therapeutics Inc.

Stock screener

Watchlist